COL4A2 and triple-negative breast carcinoma: Similarly, Type IV collagen promotes the expansion of head and neck squamous carcinoma cancer stem cells (HNSC-CSCs), and inhibiting collagen type IV alpha 2 (COL4A2) by siRNA significantly reduces the expansion and metastasis of triple-negative breast cancer (TNBC) [92].